Cell & Bioscience, 2023 · DOI: https://doi.org/10.1186/s13578-023-00967-y · Published: January 19, 2023
Spinal cord injury (SCI) often leads to inflammation, which can worsen the damage. This study explores whether activating a specific pathway, the Ang-(1–7)/MasR axis, can help reduce inflammation and improve recovery after SCI. The Ang-(1–7)/MasR axis is a naturally occurring system in the body that can regulate inflammation. The study found that activating this pathway in rats with SCI helped to reduce inflammation and promote the polarization of immune cells (microglia/macrophages) towards a healing type (M2 phenotype). By reducing inflammation and promoting M2 polarization, activating the Ang-(1–7)/MasR axis led to better functional recovery in rats with SCI. This suggests that targeting this pathway could be a potential treatment strategy for SCI.
Ang-(1–7) can be a therapeutic target for SCI treatment due to its anti-inflammatory properties.
Development of drugs activating Ang-(1–7)/MasR axis can potentially improve SCI outcomes.
Further studies are warranted to translate these findings into clinical applications for SCI patients.